Viewing StudyNCT00082602



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00082602
Status: COMPLETED
Last Update Posted: 2011-05-20
First Post: 2004-05-12

Brief Title: Safety and Tolerability Study of Extended Release ER Galantamine in Alzheimers Disease
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Alzheimers Disease
Keywords:
Name View
galantamine View
Alzheimers disease View